Logo

Catherine Mackey

Jun 18, 2015

Catherine Mackey has been elected to Sequenom's board, where she will serve on the audit and nominating, and corporate governance committees. Mackey is CEO of Cyprus Therapeutics and was previously senior VP of worldwide R&D at Pfizer. Before that, she was VP of strategic alliances at the pharma firm.

She is a special advisor to Fortis Advisors and is a director at Rady Children's Hospital. Mackey also chairs the board of Cour Pharmaceutical Development and is on the boards of Evolve Biosystems and Viventia Bio.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.